Evotec SE (OTCMKTS:EVTCY – Get Free Report) shares passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $4.09 and traded as high as $4.22. Evotec shares last traded at $4.16, with a volume of 42,681 shares.
Evotec Price Performance
The company has a market capitalization of $1.37 billion, a PE ratio of 10.15 and a beta of 0.98. The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53. The company’s 50 day moving average price is $4.09 and its 200-day moving average price is $4.07.
Evotec Company Profile
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Further Reading
- Five stocks we like better than Evotec
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Astera Labs: AI Infrastructure Play With Significant Growth Ahead
- How to start investing in penny stocks
- Is IBM’s AI Transformation Powering a Sustained Rally?
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- NVIDIA’s Stock Price Hits New Highs: This Is What’s Next
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
